Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06302569
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-08
First Post:
2024-02-16
Brief Title:
Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma
Sponsor:
Giuseppe Procopio
Organization:
Fondazione IRCCS Istituto Nazionale dei Tumori Milano
Organization Data
Organization:
Fondazione IRCCS Istituto Nazionale dei Tumori Milano
Class:
OTHER
Study ID:
Bellini INT 2024-511587-93-00
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Giuseppe Procopio
Lead Sponsor Class:
OTHER
Responsible Party:
Giuseppe Procopio
Responsible Party Title:
Director of GenitoUrinary Oncology
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Fondazione IRCCS Istituto Nazionale dei Tumori Milano
Old Name:
None
Old Organization:
None